[SY4-3] A possible role of tumor immunity against chronic myeloid leukemia cells from the viewpoint of BCR-ABL1 tyrosine kinase inhibitor discontinuation trials
Professional Experience and Education
1998 M.D., Hiroshima University, Hiroshima, Japan
2010 Ph.D., Hiroshima University, Hiroshima, Japan
2007 Assistant Professor, Hiroshima University Hospital, Japan.
2018- Higashihiroshima Medical Center, Japan.
1998 M.D., Hiroshima University, Hiroshima, Japan
2010 Ph.D., Hiroshima University, Hiroshima, Japan
2007 Assistant Professor, Hiroshima University Hospital, Japan.
2018- Higashihiroshima Medical Center, Japan.
Abstract password authentication.
Password is written on a program and abstract book.